FDA approves first live, non-replicating vaccine to prevent smallpox and monkeypox - FDA Press Releases

The U.S. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection. This is the

from FDA Press Releases RSS Feed https://ift.tt/2lqnYZW
via IFTTT